ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.
Follow-Up Questions
Who is the CEO of Asep Medical Holdings Inc?
Dr. Robert Hancock is the Chief Executive Officer of Asep Medical Holdings Inc, joining the firm since 2021.
What is the price performance of SEPSF stock?
The current price of SEPSF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Asep Medical Holdings Inc?
Asep Medical Holdings Inc belongs to N/A industry and the sector is N/A
What is Asep Medical Holdings Inc market cap?
Asep Medical Holdings Inc's current market cap is $0
